Multitarget Molecular Imaging in Metastatic Castration Resistant Adenocarcinoma Prostate Cancer with Therapy Induced Neuroendocrine Differentiation.
PET/CT
molecular imaging
neuroendocrine differentiation
prostate cancer
Journal
Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402
Informations de publication
Date de publication:
03 Jun 2022
03 Jun 2022
Historique:
received:
16
03
2022
revised:
05
04
2022
accepted:
06
04
2022
entrez:
24
6
2022
pubmed:
25
6
2022
medline:
25
6
2022
Statut:
epublish
Résumé
Neuroendocrine differentiation of prostate cancer (NEDPC) includes de novo presentation and secondary to epigenetic changes, referred as therapy-induced neuroendocrine prostate cancer (t-NEPC). Molecular imaging with prostate-specific membrane antigen (PSMA) and somatostatin analogues positron emission tomography (PET/CT) in NEDPC have not been validated.
Identifiants
pubmed: 35741197
pii: diagnostics12061387
doi: 10.3390/diagnostics12061387
pmc: PMC9221809
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Cancers (Basel). 2020 Dec 16;12(12):
pubmed: 33339136
Clin Nucl Med. 2019 Jan;44(1):e28-e32
pubmed: 30394930
Clin Nucl Med. 2018 Apr;43(4):248-249
pubmed: 29474196
Front Oncol. 2015 Apr 14;5:90
pubmed: 25927031
J Cell Biochem. 2012 Feb;113(2):553-62
pubmed: 21938742
Cancers (Basel). 2021 Nov 17;13(22):
pubmed: 34830919
Cancers (Basel). 2019 Sep 20;11(10):
pubmed: 31547070
Nat Rev Urol. 2016 Apr;13(4):226-35
pubmed: 26902337
J Nucl Med. 2017 Sep;58(9):1452-1458
pubmed: 28280220
Cancer Res. 2016 Sep 1;76(17):4948-58
pubmed: 27302169
Eur Urol Oncol. 2019 Nov;2(6):670-676
pubmed: 31412006
Anticancer Res. 2010 Feb;30(2):369-74
pubmed: 20332441
J Clin Oncol. 2002 Jul 15;20(14):3072-80
pubmed: 12118020
Eur Urol. 2019 Jan;75(1):88-99
pubmed: 29673712
Endocr Relat Cancer. 2018 Oct 1;26(2):131-146
pubmed: 30400059
Lancet. 2020 Apr 11;395(10231):1208-1216
pubmed: 32209449
J Clin Oncol. 2018 Aug 20;36(24):2492-2503
pubmed: 29985747
Eur J Cancer. 2019 Nov;121:7-18
pubmed: 31525487
Prostate. 2014 Aug;74(11):1153-9
pubmed: 24913988
Front Oncol. 2021 Jul 29;11:683793
pubmed: 34395251
N Engl J Med. 2021 Sep 16;385(12):1091-1103
pubmed: 34161051
Endocr Relat Cancer. 2012 Oct 30;19(6):R187-204
pubmed: 22930558
J Nucl Med. 2019 Jun;60(6):786-793
pubmed: 30530831
Cancer Discov. 2011 Nov;1(6):487-95
pubmed: 22389870
Clin Nucl Med. 2017 Jan;42(1):1-6
pubmed: 27775942
Clin Genitourin Cancer. 2021 Aug;19(4):e200-e205
pubmed: 33678552
J Natl Compr Canc Netw. 2019 May 1;17(5):479-505
pubmed: 31085757
Asian J Urol. 2019 Jan;6(1):82-90
pubmed: 30775251
Clin Nucl Med. 2017 May;42(5):410-413
pubmed: 28240661
J Nucl Med. 2020 Jun;61(6):904-910
pubmed: 31806771